Jeff Lagasse

August 24, 2017
DePuy Synthes has entered into an exclusive agreement with JointPoint Inc. to co-market a proprietary software platform that aims to help surgeons perform hip replacement surgeries.   JointPoint's software provides non-invasive computer navigation, presurgical digital templating, case planning and feedback during such surgeries, and it easily integrates with the Anterior Approach. The Anterior...
August 23, 2017
Precision medicine company GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures, with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company's REFS causal machine learning and simulation platform -- as well as solutions across drug discovery and development, value-based drug solutions, and care...
August 23, 2017
A study led by researchers at Cedars-Sinai and NeuroVision Imaging LLC provides a scientific basis for using noninvasive eye imaging to essentially detect signs of Alzheimer’s. The experimental technology, developed by Cedars-Sinai and NeuroVision, scans the retina using techniques that can identify beta-amyloid protein deposits that mirror those in the brain.   Accumulations of neurotoxic beta-...
August 22, 2017
Stride Health, a company that provides benefits for independent workers, has raised $23.5 million in a Series B financing round led by F-Prime Capital Partners, with participation from existing investors Venrock and New Enterprise Associates -- as well as new investors, including Portag3 Ventures.   The additional capital will fuel the expansion of Stride Health’s benefits offerings, with an eye...
August 21, 2017
IBM and JDRF, a global organization funding Type 1 diabetes research, are joining forces. The collaboration will develop machine learning methods and use them to analyze years of Type 1 research data to pinpoint the factors that can contribute to the onset of the condition in children.   Type 1 diabetes  -- T1D for short -- affects about 1.25 million Americans, and to date does not have a cure....
August 21, 2017
If Samsung Electronics has anything to say about it, those with visual impairments will soon be able to use their smartphones to make things a bit clearer. Samsung is launching Relúmĭno, a visual aid application that works in conjunction with the Gear VR. The app processes images from videos projected through the rear camera of a smartphone, and makes the images a little more friendly for the...
August 17, 2017
Personal Genomics company Helix has partnered up with Illumina Accelerator, a business accelerator focused solely on creating an innovation ecosystem for the genomics industry. As part of the collaboration, they’ll team with entrepreneurs with an eye toward innovation and the development of DNA-driven products and insights for consumers. The partnership is all in the family: Helix originally spun...
August 17, 2017
The wearables market continues to generate a lot of attention, both positive and negative. Fitness trackers and smartwatches remain the flag bearers of the wearable market, seeing growth but at a slower pace than has been estimated, according to a new report from Tractica.   Meanwhile, other wearable device categories such as body sensors continue to show strong promise, driven largely by...
August 16, 2017
Diabetes therapy management software company Glytec has just secured its fourth FDA clearance, adding a slew of capabilities to its Glucommander product, the core of its eGlycemic Management System.   This latest FDA clearance incorporates some of the product enhancements that have been suggested by the company’s user community, including a titration module designed expressly for inpatients...
August 16, 2017
Artemis Health, which offers a benefit optimization data platform for employers, just received $16 million in Series B funding, led by an investment from F-Prime Capital, the venture capital funds of FMR LLC, the parent company of Fidelity Investments. There was also participation in the round from Maverick Ventures and Kickstart Seed Fund, both previous investors. This is the second major round...